2018
$200M
from 11 investors over 11 rounds
Phathom Pharmaceuticals raised $40M on November 1, 2022
Investors: - and Hercules Capital, Inc.
Phathom Pharmaceuticals raised $200M on September 20, 2021
Investors: Hercules Capital, Inc.
Phathom Pharmaceuticals raised $90M on May 15, 2019
Investors: Greenspring Associates, Sahsen Ventures, LLC, Catalys Pacific, Medicxi, Takeda UK Limited, Frazier Healthcare Partners, Richard King Mellon Foundation and RA Capital Management, L.P.